Bevurogant

Modify Date: 2025-08-27 09:53:54

Bevurogant Structure
Bevurogant structure
Common Name Bevurogant
CAS Number 1817773-66-2 Molecular Weight 532.62
Density N/A Boiling Point N/A
Molecular Formula C26H28N8O3S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Bevurogant


Bevurogant is a retinoid-related orphan receptor-gamma t (RORγt) antagonist. Bevurogant can be used for the research of chronic inflammatory diseases[1].

 Names

Name Bevurogant

 Bevurogant Biological Activity

Description Bevurogant is a retinoid-related orphan receptor-gamma t (RORγt) antagonist. Bevurogant can be used for the research of chronic inflammatory diseases[1].
Related Catalog
References

[1]. BAKONYI J, et, al. Compounds as modulators of ror gamma. US20150291607A1.

 Chemical & Physical Properties

Molecular Formula C26H28N8O3S
Molecular Weight 532.62
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here



Get all suppliers and price by the below link:

Bevurogant suppliers

Bevurogant price

Related Compounds: More...
3-Oxazolidinepentanoic acid,-[(S)-[(4-fluorophenyl)amino][4-(2-propen-1-yloxy)phenyl]methyl]-,2-dioxo-4-phenyl-, phenylmethyl ester, (R,4S)-
1202579-22-3
4-O-tert-butyl 1-O-[(3R,5R,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-5-[(2-methylpropan-2-yl)oxy]-5-oxopentan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] (2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)butanedioate
1202710-63-1
[1,1'-Biphenyl]-4-propanoic acid,-(acetylamino)-, (R)-, compd. with (S)--methylbenzenemethanamine (1:1)
1236479-65-4
tert-butyl N-[(2S)-1-[[(1S)-2-[(2S)-2-carbamoyl-3-[(1S,2R)-2-[6-[[(1S,2R)-1-[(2S)-2-carbamoyl-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]propanoyl]amino]acetyl]pyrrolidin-3-yl]-2,3-dihydro-1H-inden-2-yl]oxy]hexa-2,4-diynoxy]-2,3-dihydro-1H-inden-1-yl]pyrrolidin-1-yl]-1-cyclohexyl-2-oxoethyl]amino]-1-oxopropan-2-yl]-N-methylcarbamate
1258392-64-1
[4-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-6-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoyl]amino]phenyl]methyl (6S,6aS)-3-[5-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-6-hydroxy-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepine-5-carboxylate
1343476-22-1
methyl 2-(3-aminopropoxy)-4-[(E)-3-(3,5-ditert-butylphenyl)-3-oxoprop-1-enyl]benzoate;hydrochloride
1351169-37-3
H-Asn-Leu-Gly-Val-Cys(Acm)-NH2
136467-00-0
[(2R,3R,4R,5R)-5-(6-benzamidopurin-9-yl)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[tert-butyl(dimethyl)silyl]oxyoxolan-3-yl] 2-cyanoethyl prop-2-enyl phosphate
1427449-37-3
[(2R,3R,4R,5R)-5-(6-benzamidopurin-9-yl)-2-[[[(2R,3R,4R,5R)-5-(6-benzamidopurin-9-yl)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[tert-butyl(dimethyl)silyl]oxyoxolan-3-yl]oxy-(2-cyanoethoxy)phosphoryl]oxymethyl]-4-[tert-butyl(dimethyl)silyl]oxyoxolan-3-yl] 2-cyanoethyl prop-2-enyl phosphate
1427449-39-5
D-Glucose, 2-deoxy-6-O-[2-deoxy-2-[[1-oxo-3-[(1-oxododecyl)oxy]tetradecyl]amino]-3-O-[1-oxo-3-[(1-oxotetradecyl)oxy]tetradecyl]-4-O-phosphono--D-glucopyranosyl]-2-[[1-oxo-3-[(1-oxohexadecyl)oxy]tetradecyl]amino]-
147219-31-6